• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.行政数据与科学证据：来自法国的经验教训——COVID-19 大流行期间银屑病的系统治疗安全性。
Br J Dermatol. 2022 Jan;186(1):7-8. doi: 10.1111/bjd.20776. Epub 2021 Nov 2.
2
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.银屑病相关治疗暴露与 COVID-19 大流行第一波和第二波期间的住院或院内死亡率：法国 1326312 例患者的队列研究。
Br J Dermatol. 2022 Jan;186(1):59-68. doi: 10.1111/bjd.20659. Epub 2021 Aug 31.
3
Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic.银屑病患者的感染风险。在 SARS-CoV-2 大流行期间得到的教训。
Br J Dermatol. 2021 Jan;184(1):6. doi: 10.1111/bjd.19190. Epub 2020 Jun 15.
4
Clinical management of psoriasis patients during the COVID-19 pandemic.COVID-19 大流行期间银屑病患者的临床管理。
J Dermatolog Treat. 2022 Mar;33(2):1166-1167. doi: 10.1080/09546634.2020.1781045. Epub 2020 Jun 22.
5
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic.新冠疫情期间银屑病患者生物制剂起始治疗率下降。
Br J Dermatol. 2021 Sep;185(3):671-673. doi: 10.1111/bjd.20406. Epub 2021 Jun 14.
6
[BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].[新型冠状病毒感染COVID-19期间银屑病的生物治疗]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2021 Aug;29(Special Issue):1381-1387. doi: 10.32687/0869-866X-2021-29-s2-1381-1387.
7
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?在新冠疫情期间，化脓性汗腺炎的生物治疗与银屑病的生物治疗有何不同？
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
8
Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort.COVID-19 大流行第一波对法国系统性治疗银屑病的影响：来自 PSOBIOTEQ 队列的结果。
Ann Dermatol Venereol. 2023 Jun;150(2):101-108. doi: 10.1016/j.annder.2023.01.005. Epub 2023 Feb 15.
9
Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.COVID-19 大流行时期银屑病患者的免疫抑制药物。综述。
Dermatol Ther. 2021 Jan;34(1):e14498. doi: 10.1111/dth.14498. Epub 2020 Nov 10.
10
Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.".致编辑的信，关于文章《奥古兹·托帕尔一世、卡拉·波拉特 A、津丹奇 İ 等人。COVID-19 大流行期间银屑病患者对系统治疗的依从性：一项多中心研究。《美容皮肤病学杂志》。2021 年；10.1111/jocd.14610》。
J Cosmet Dermatol. 2022 Mar;21(3):880-882. doi: 10.1111/jocd.14781. Epub 2022 Jan 27.

本文引用的文献

1
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence.评估生物治疗下患有银屑病或银屑病关节炎患者的 COVID-19 风险和结局：对已发表证据质量的批判性评价。
J Invest Dermatol. 2022 Feb;142(2):355-363.e7. doi: 10.1016/j.jid.2021.04.036. Epub 2021 Aug 4.
2
Socioeconomic variation in characteristics, outcomes, and healthcare utilization of COVID-19 patients in New York City.纽约市 COVID-19 患者的特征、结局和医疗保健利用的社会经济差异。
PLoS One. 2021 Jul 29;16(7):e0255171. doi: 10.1371/journal.pone.0255171. eCollection 2021.
3
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.银屑病相关治疗暴露与 COVID-19 大流行第一波和第二波期间的住院或院内死亡率：法国 1326312 例患者的队列研究。
Br J Dermatol. 2022 Jan;186(1):59-68. doi: 10.1111/bjd.20659. Epub 2021 Aug 31.
4
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.越来越多的证据表明，在新冠病毒病治疗中，抗TNF治疗需要优先进行试验。
Lancet Rheumatol. 2020 Nov;2(11):e653-e655. doi: 10.1016/S2665-9913(20)30309-X. Epub 2020 Sep 5.
5
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.国家银屑病基金会 COVID-19 工作组关于大流行期间银屑病管理的指南：第 2 版-银屑病管理、COVID-19 疫苗和 COVID-19 治疗的进展。
J Am Acad Dermatol. 2021 May;84(5):1254-1268. doi: 10.1016/j.jaad.2020.12.058. Epub 2021 Jan 7.
6
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.接受生物治疗的银屑病患者因 COVID-19 住院和死亡的发生率：意大利北部的经验。
J Allergy Clin Immunol. 2021 Feb;147(2):558-560.e1. doi: 10.1016/j.jaci.2020.10.032. Epub 2020 Nov 5.
7
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.COVID-19 患者使用肿瘤坏死因子抑制剂或甲氨蝶呤的临床结局：一项多中心研究网络研究。
J Am Acad Dermatol. 2021 Jan;84(1):70-75. doi: 10.1016/j.jaad.2020.09.009. Epub 2020 Sep 11.
8
Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey.关于2019冠状病毒病大流行对接受全身免疫调节治疗的特应性皮炎和银屑病成年患者影响的关注：一项丹麦问卷调查
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e773-e776. doi: 10.1111/jdv.16863. Epub 2020 Sep 17.
9
More on Covid-19 in Immune-Mediated Inflammatory Diseases.关于免疫介导的炎症性疾病中的新冠病毒病更多内容
N Engl J Med. 2020 Aug 20;383(8):795-796. doi: 10.1056/NEJMc2018011. Epub 2020 Jul 10.
10
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.银屑病患者接受全身治疗或生物治疗不会增加患重症 COVID-19 的风险。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.

行政数据与科学证据：来自法国的经验教训——COVID-19 大流行期间银屑病的系统治疗安全性。

Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.

机构信息

Centro Studi GISED, Bergamo, Italy.

Department of Dermatology, Inselspital University Hospital, Bern, Switzerland.

出版信息

Br J Dermatol. 2022 Jan;186(1):7-8. doi: 10.1111/bjd.20776. Epub 2021 Nov 2.

DOI:10.1111/bjd.20776
PMID:34726776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652619/
Abstract

Penso . 2022; :59–68.

摘要

彭索. 2022; :59–68.